VIVODYNE

vivodyne-logo

Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies. Its platform cultures the most realistic human tissues ever lab-grown to answer deep questions about human health.

#SimilarOrganizations #People #Financial #Event #Website #More

VIVODYNE

Social Links:

Industry:
Biotechnology Lifestyle Medical

Founded:
2020-01-01

Address:
Philadelphia, Pennsylvania, United States

Country:
United States

Website Url:
http://www.vivodyne.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
40 M USD

Technology used in webpage:
Domain Not Resolving Cloudflare Hosting Facebook Sharer U.S. Server Location HSTS IncludeSubdomains PreLoad Amazon SSL Next.js Apollo GraphQL Auth0 Chakra UI


Similar Organizations

aspect-biosystems-logo

Aspect Biosystems

Biotech company developing bioprinted tissue therapeutics to transform how we treat disease.

clarapath-logo

Clarapath

We are a medical robotics company developing the SectionStar, a platform to mimic the human histotechnician.

modicus-prime-logo

Modicus Prime

Bringing Self-Service AI to the Life Sciences

proscia-logo

Proscia

Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.

revir-therapeutics-logo

ReviR Therapeutics

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

serve-robotics-logo

Serve Robotics

Serve Robotics develops self-driving robots to deliver food and supplies.

virgin-pulse-logo

Virgin Pulse

Virgin Pulse is a software company that offers services in employee engagement, productivity, employee health, and workplace wellness.

Current Employees Featured

elliot-menschik_image

Elliot Menschik
Elliot Menschik Chief Technology Officer & Member Board of Directors @ Vivodyne
Chief Technology Officer & Member Board of Directors
2024-01-01

andrei-georgescu_image

Andrei Georgescu
Andrei Georgescu Co-Founder and CEO @ Vivodyne
Co-Founder and CEO

dan-huh_image

Dan Huh
Dan Huh Co-Founder and CSO @ Vivodyne
Co-Founder and CSO

Founder


andrei-georgescu_image

Andrei Georgescu

dan-huh_image

Dan Huh

Investors List

kairos-venture-investments-llc_image

Kairos Ventures

Kairos Ventures investment in Seed Round - Vivodyne

khosla-ventures_image

Khosla Ventures

Khosla Ventures investment in Seed Round - Vivodyne

cs-venture-opportunities-fund_image

CS Venture Opportunities Fund

CS Venture Opportunities Fund investment in Seed Round - Vivodyne

mbx-capital_image

MBX Capital

MBX Capital investment in Seed Round - Vivodyne

bison-ventures_image

Bison Ventures

Bison Ventures investment in Seed Round - Vivodyne

kairos-venture-investments-llc_image

Kairos Ventures

Kairos Ventures investment in Seed Round - Vivodyne

Key Employee Changes

Date New article
2024-01-31 Vivodyne Appoints Elliot Menschik, M.D., Ph.D., as Chief Technology Officer

Official Site Inspections

http://www.vivodyne.com Semrush global rank: 5.46 M Semrush visits lastest month: 1.35 K

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 99.83.190.102
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Vivodyne"

Vivodyne - Crunchbase Company Profile & Funding

Vivodyne develops lifelike human organs for drug testing and research purposes. The company utilizes robotic systems and artificial intelligence to create realistic human tissues that simulate various organ functions. ... The โ€ฆ See details»

Vivodyne 2025 Company Profile: Valuation, Funding & Investors

Vivodyne General Information Description. Developer of a platform designed to provide a more accurate and efficient method for preclinical drug testing. The company's platform utilizes lab โ€ฆ See details»

Vivodyne - 2025 Company Profile, Funding & Competitors - Tracxn

May 30, 2025 Vivodyne is a series A company based in Philadelphia (United States), founded in 2021 by Dan Huh. It operates as a Developer of AI-based platform for lab-grown human tissues. โ€ฆ See details»

Vivodyne Company Profile - Office Locations, Competitors ... - Craft

Vivodyne has 5 employees at their 1 location and $42 m in total funding,. See insights on Vivodyne including office locations, competitors, revenue, financials, executives, subsidiaries and more at โ€ฆ See details»

Vivodyne to Replace Animal Testing With $40 Million Funding to โ€ฆ

May 29, 2025 Vivodyne Chief Operating Officer Julie O'Shaughnessy (L) and Vivodyne CEO Andrei Georgescu (R). 95% of clinical trials fail because animal testing is no substitute for human biology โ€ฆ See details»

Vivodyne - A Kairos Ventures Portfolio Company

Vivodyne is changing how scientists study human biology & develop therapeutics. Their platform technology creates a new preclinical drug development pipeline โ€“ Pipeline V โ€“ that starts and ends in lab-grown human โ€ฆ See details»

This Startup Raised $38 Million To Fill One Of The โ€ฆ

Nov 22, 2023 Vivodyne CEO Andrei Georgescu (L) and Chief Commercial Officer Susan Billings (R). VivoDyne. Only about 10% of drugs in development ever make it to market. That number has remained largely ... See details»

Vivodyne | F6S

Vivodyne software Vivodyne Platform Health/Medical Biotech Robotics AI (Artificial Intelligence) Drug Discovery High-Throughput Screening Predictive AI Preclinical Testing Lab-Grown Human โ€ฆ See details»

About Us - Vivodyne

At Vivodyne, Andrew spearheads the development and implementation of cutting-edge robotic technology crucial for advancing human organ tissue production for drug discovery. Previously, he played pivotal roles in โ€ฆ See details»

Mission, Vision & Core Values of Vivodyne

Dec 7, 2024 At Vivodyne, our mission statement plays a crucial role in driving innovation within our organization. Our mission to develop an automated robotic system that discovers life-changing โ€ฆ See details»

Vivodyne raises $40 million in funding round led by Khosla Ventures

May 29, 2025 Vivodyne has raised about $78 million to date, after a $38 million seed round in 2023. CEO Andrei Georgescu wouldn't disclose Vivodyne's valuation but said it grew significantly with โ€ฆ See details»

This startup is solving the biggest problems in drug development

Dec 9, 2023 While Vivodyne isnโ€™t the first group to create lab-grown human tissues for drug testing, it has figured out how to automate and dramatically scale the process โ€” its robotic platform can โ€ฆ See details»

Careers - Vivodyne

As a team, every corner of the organization brings their insights and ideas to the table. The winning solutions are always based on their ability to accelerate our capabilities, not politics or hierarchy. โ€ฆ See details»

Vivodyne raised $38 million to fill drug discovery gap - Forbes Australia

Nov 22, 2023 Vivodyneโ€™s key technological innovation, Georgescu says, is the ability to grow 22 different types of human tissue that can be used to model blood flow and other interactions โ€ฆ See details»

Vivodyne to Replace Animal Testing With $40 Million Funding to โ€ฆ

About Vivodyne Vivodyne is rendering inaccurate animal testing obsolete, using automated robotic platforms and AI to grow and analyze thousands of fully functional human tissues. โ€ฆ See details»

Vivodyne to Replace Animal Testing With $40 Million Funding

May 29, 2025 Vivodyne has raised $40 million in new Series A financing to scale its robotics+AI approach to testing on thousands of lab-grown, fully-functional human tissues, and the massive โ€ฆ See details»

Vivodyne Raises $38M in Seed Funding to Advance Lab-Grown โ€ฆ

Nov 22, 2023 Vivodyneโ€™s innovative platform seeks to address one of the major bottlenecks in drug development, offering a solution for gathering human-predictive data that is both realistic and โ€ฆ See details»

Vivodyne raised $40 million from Khosla Ventures and others

4 days ago Vivodyne, a Penn spinout that creates human tissue to replace animal testing in drug development, has raised $40 million in a second round of venture capital investment. The โ€ฆ See details»

Our Platform - Vivodyne

Vivodyne Announces Another $40M in Series A Financing. Platform. Platform. Overview. ... Our 3D human tissues are designed to reconstitute the cellular, tissue, organ, and systemic organization โ€ฆ See details»

Vivodyne - Partnerships

Vivodyne Announces Another $40M in Series A Financing. Platform. Platform. Overview. Our platform accelerates the development of new therapies with preclinical human data. learn more. โ€ฆ See details»

linkstock.net © 2022. All rights reserved